BREAKING NEWS; FTC Sues Major Pharmacy Benefit Managers Over Insulin Pricing Practices
The FTC Sues against major pharmacy benefit managers concerning insulin pricing practices The U.S. Federal Trade Commission (FTC) has launched a lawsuit against the nation’s three largest pharmacy benefit managers (PBMs)—UnitedHealth Group Inc’s Optum, CVS Health Corp’s CVS Caremark, and Cigna Corp’s Express Scripts—alleging that they unfairly steered diabetes patients toward higher-priced insulin products in ...
